Zimmer Biomet Holdings, Inc.
ZBH Healthcare Medical Devices
Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024. In the quarter to June 2026, revenue grew 4.80%, EPS grew 33.8%, free cash flow grew 13.1% and total debt fell 1.23%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five.
Follow ZBH
Zimmer Biomet Holdings, Inc. (ZBH) EV/FCF
As of 16 October 2026, Zimmer Biomet Holdings, Inc. (ZBH) trades at a EV/FCF of 24.4×. Over the past ten years it has ranged from 21.1× (December 2018) to 141× (April 2021); the current reading is higher than 12% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 23.0× | (33.78%) |
| FY2024 | 34.7× | (1.11%) |
| FY2023 | 35.1× | (4.49%) |
| FY2022 | 36.7× | 10.75% |
| FY2021 | 33.1× | (56.15%) |
| FY2020 | 75.6× | 63.81% |
| FY2019 | 46.1× | 108.94% |
| FY2018 | 22.1× | (29.13%) |
| FY2017 | 31.2× | 11.94% |
| FY2016 | 27.8× | (59.78%) |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Jun 2026 | 22.8× | (6.93%) |
| Mar 2026 | 24.5× | 6.64% |
| Dec 2025 | 23.0× | (11.84%) |
| Sep 2025 | 26.0× | 7.13% |
| 42 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | 7.7× |
| GMED Globus Medical, Inc. compare | 14.4× |
| PHG Koninklijke Philips N.V. compare | 16.1× |
| DXCM DexCom, Inc. compare | 23.5× |
| ZBH Zimmer Biomet Holdings, Inc. | 24.4× |
| STE STERIS plc compare | 24.7× |
| GEHC GE HealthCare Technologies Inc. compare | 25.9× |
| BIO.B Bio-Rad Laboratories, Inc. compare | 26.3× |
| PEN Penumbra, Inc. compare | 55.5× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on ZBH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement